The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Relapse and Rehospitalization During Maintenance Treatment of Schizophrenia: The Effects of Dose Reduction and Family Treatment
Abstract
BACKGROUND: Previous studies have examined dose reduction and family treatment in schizophrenia, but none has examined their interaction. This study assessed the impact of dose reduction of antipsychotic medication and family treatment on relapse and rehospitalization during maintenance treatment. METHODS: Subjects were 313 male and female outpatients at 5 centers with a DSM-III-R diagnosis of schizophrenia or schizoaffective disorder. In a 3 x 2 design, subjects were randomized to 1 of 3 medication strategies using fluphenazine decanoate under double-blind conditions: continuous moderate dose (standard) (12.5-50 mg every 2 weeks); continuous low dose (2.5-10 mg every 2 weeks); or targeted, early intervention (fluphenazine only when symptomatic). Subjects also were randomized to 1 of 2 family treatment strategies (supportive or applied). Supportive family management involved monthly group meetings. The more intensive applied family management involved monthly group meetings and home visits where communication and problem-solving skills were taught. Patients and families were treated and assessed for 2 years. RESULTS: Both continuous low-dose and targeted treatment increased use of rescue medication and relapse; only targeted treatment increased rehospitalization. This pattern was consistent across both family treatments; there were no differences between family treatments. CONCLUSIONS: These findings reaffirm the value of antipsychotic medication in preventing relapse and rehospitalization. The absence of family treatment differences may be because both conditions engaged families.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
(1976) · Medical Entomology and Zoology · Cited by 8,899
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,234
Pocock, S. J., & Simon, R. (1975) · Biometrics · doi:10.2307/2529712 · Cited by 2,350
Risperidone in the treatment of schizophrenia
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.6.825 · Cited by 1,193
Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised
Kobylski, T. P. (1988) · Psychosomatics · doi:10.1016/s0033-3182(88)72438-x · Cited by 1,054
Hogarty, G. E. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800070019003 · Cited by 917
A Controlled Trial of Social Intervention in the Families of Schizophrenic Patients
Leff, J., Kuipers, L., Berkowitz, R., Eberlein-Vries, R., & Sturgeon, D. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.141.2.121 · Cited by 869
Family Management in the Prevention of Exacerbations of Schizophrenia: A Controlled Study
Falloon, I. R. H., Boyd, J. L., McGill, C. W., Razani, J., Moss, H. B., & Gilderman, A. M. (1982) · New England Journal of Medicine · doi:10.1056/nejm198206173062401 · Cited by 683
Falloon, I. R. H. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790320059008 · Cited by 586
Multiple-Family Groups and Psychoeducation in the Treatment of Schizophrenia
McFarlane, W. R. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950200069016 · Cited by 560
Drug and Family Therapy in the Aftercare of Acute Schizophrenics
Goldstein, M. J. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770340019001 · Cited by 517
Hogarty, G. E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810280056008 · Cited by 504
Tarrier, N., Barrowclough, C., Vaughn, C., Bamrah, J. S., Porceddu, K., Watts, S., & Freeman, H. (1988) · British Journal of Psychiatry · doi:10.1192/bjp.153.4.532 · Cited by 464
(1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.7.801 · Cited by 455
Overview: maintenance therapy in psychiatry: I. Schizophrenia
(1975) · American Journal of Psychiatry · doi:10.1176/ajp.132.12.1237 · Cited by 410
Leff, J., Kuipers, L., Berkowitz, R., & Sturgeon, D. (1985) · British Journal of Psychiatry · doi:10.1192/bjp.146.6.594 · Cited by 399
Anchoring the BPRS: an aid to improved reliability.
Woerner, M. G., Mannuzza, S., & Jm, K. (1988) · PubMed · Cited by 341
A Trial of Family Therapy v. a Relatives Group for Schizophrenia
Leff, J., Berkowitz, R., Shavit, N., Strachan, A., Glass, I., & Vaughn, C. (1989) · British Journal of Psychiatry · doi:10.1192/bjp.154.1.58 · Cited by 287
Kane, J. M. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790070083010 · Cited by 273
Psychopharmacologic Treatment of Schizophrenia
Kane, J. M., & Marder, S. R. (1993) · Schizophrenia Bulletin · doi:10.1093/schbul/19.2.287 · Cited by 273
Tarrier, N., Barrowclough, C., Vaughn, C., Bamrah, J. S., Porceddu, K., Watts, S., & Freeman, H. (1989) · British Journal of Psychiatry · doi:10.1192/bjp.154.5.625 · Cited by 251
Low- and Conventional-Dose Maintenance Therapy With Fluphenazine Decanoate: Two-Year Outcome
Marder, S. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800180028005 · Cited by 245
Hogarty, G. E. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330021002 · Cited by 239
Psychosocial Treatment for Schizophrenia
Bellack, A. S., & Mueser, K. T. (1993) · Schizophrenia Bulletin · doi:10.1093/schbul/19.2.317 · Cited by 239
Intermittent vs Maintenance Medication in Schizophrenia: Two-Year Results
Herz, M. I. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810280049007 · Cited by 205
(1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.9.1138 · Cited by 192
Allocation of patients to treatment groups in a controlled clinical study
White, S. J., & Freedman, L. S. (1978) · British Journal of Cancer · doi:10.1038/bjc.1978.124 · Cited by 191
A Trial of Family Therapy versus a Relatives' Group for Schizophrenia: Two-Year Follow-up
Leff, J., Berkowitz, R., Shavit, N., Strachan, A., Glass, I., & Vaughn, C. (1990) · British Journal of Psychiatry · doi:10.1192/bjp.157.4.571 · Cited by 184
Costs and Benefits of Two Doses of Fluphenazine
Marder, S. R. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790220015002 · Cited by 182
Jolley, A. G., Hirsch, S. R., Morrison, E., McRink, A., & Wilson, L. (1990) · BMJ · doi:10.1136/bmj.301.6756.837 · Cited by 171
(1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.7.918 · Cited by 168
Jolley, A., Hirsch, S. R., McRink, A., & Manchanda, R. (1989) · BMJ · doi:10.1136/bmj.298.6679.985 · Cited by 130
Behavioural Family Management in Schizophrenia
Randolph, E. T., Eth, S., Glynn, S. M., Paz, G. G., Leong, G. B., Shaner, A. L., STRACHAN, A. M., Vort, W. B. V., Escobar, J. I., & Liberman, R. P. (1994) · The British Journal of Psychiatry · doi:10.1192/bjp.164.4.501 · Cited by 120
Johnson, D. A. W., Ludlow, J. M., Street, K., & Taylor, R. D. W. (1987) · The British Journal of Psychiatry · doi:10.1192/bjp.151.5.634 · Cited by 108
A multisite investigation of the reliability of the Scale for the Assessment of Negative Symptoms
Mueser, K. T., Sayers, S. L., Schooler, N. R., Mance, R., & Haas, G. L. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.10.1453 · Cited by 104
Self-citationDrug-induced extrapyramidal disorders.
Chase, T. N. (1972) · PubMed · Cited by 104
Maintenance Medication for Schizophrenia: Strategies for Dose Reduction
Schooler, N. R. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.2.311 · Cited by 97
Self-citationPietźcker, A., Gäebel, W., Köpcke, W., Linden, M., Müller, P., Müller-Spahn, F., & Tegeler, J. (1993) · Journal of Psychiatric Research · doi:10.1016/0022-3956(93)90059-b · Cited by 83
Subject Selection Biases in Clinical Trials
Robinson, D. G., Woerner, M. G., Pollack, S. Z., & Lerner, G. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199604000-00009 · Cited by 78
Depot neuroleptics: a comparative review of standard, intermediate, and low-dose regimens.
Kane, J. M., Woerner, M. G., & Sarantakos, S. (1986) · PubMed · Cited by 62
Family management of schizophrenia: A comparison of behavioral and supportive family treatment
Zastowny, T. R., Lehman, A. F., Cole, R. E., & Kane, C. F. (1992) · Psychiatric Quarterly · doi:10.1007/bf01065988 · Cited by 58
Nr, S., Sj, K., Severe, J. B., & Matthews, S. (1989) · PubMed · Cited by 37
Maintenance treatment of schizophrenia: A review of dose reduction and family treatment strategies
Schooler, N. R., Keith, S. J., Severe, J. B., & Matthews, S. (1995) · Psychiatric Quarterly · doi:10.1007/bf02238750 · Cited by 24
Self-citationFalloon, I. R. H., Mcgill, C. W., Matthews, S., Keith, S. J., & Schooler, N. R. (1996) · PubMed · Cited by 22
Self-citationSj, K., Bellack, A. S., Frances, A., Mance, R., & Matthews, S. (1989) · PubMed · Cited by 14
Glick, I. D., Jacobs, M., Lieberman, J. A., Simpson, G., & Nr, S. (1989) · PubMed · Cited by 13
Hargreaves, W. A., Kane, J. M., Ninan, P. T., Severe, J. B., & Woerner, M. G. (1989) · PubMed · Cited by 6
Cited by
The Burden of Schizophrenia on Caregivers: A Review
Awad, A. G., & Voruganti, L. N. P. (2008) · PharmacoEconomics · doi:10.2165/00019053-200826020-00005 · Cited by 809
Family intervention for schizophrenia
Pharoah, F., Mari, J., Rathbone, J., & Wong, W. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000088.pub2 · Cited by 737
Increased dopamine transmission in schizophrenia: relationship to illness phases
Laruelle, M., Abi-Dargham, A., Gil, R., Kegeles, L., & Innis, R. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00067-0 · Cited by 715
Pitschel-Walz, G., Leucht, S., Bauml, J., Kissling, W., & Engel, R. R. (2001) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006861 · Cited by 648
Baucom, D. H., Shoham, V., Mueser, K. T., Daiuto, A. D., & Stickle, T. R. (1998) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.66.1.53 · Cited by 608
Metadata
- Authors
- Schooler, N. R.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 1997-05-01
- Volume
- 54
- Issue
- 5
- Pages
- 453
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2115409268
- Cited by
- 298
- References
- 48
- FWCI
- 16.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.